Remove Communication Remove Generic Medicine Remove Pharmaceutical Manufacturing
article thumbnail

Omnibus Spending Law: Provisions Will Bolster Medicines Supply Chain Insights and Advanced Manufacturing Technologies

Quality Matters

Leveraging insights from data on USP standards distribution and usage at more than 22,000 locations worldwide and 40+ external data sets, USP launched the Medicine Supply Map in 2021 to provide an early-warning capability for supply chain vulnerabilities.

article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

That way…we can do our best to communicate with you about how to best prepare a submission.” While there may be certain regulatory challenges, “there are no regulatory barriers to the adoption of continuous manufacturing, only potentially perceived ones,” asserted presenter Riley Myers, Ph.D.,

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

To build an advanced pharmaceutical manufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceutical manufacturers. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9